Whereas critical illness reduced muscle weight under placebo, this effect failed to reach statistical significance in LY245319 -treated mice (Fig. 4 f).
← all excerpts
Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
1
—
—